Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Damas

Showing results (201-210 of 219) with videos related to

Pageof 22
Sort By:
European Journal of Pharmacology|January 5, 2000
Effects of JL 3, a putative antidepressant, on rat noradrenergic and serotonergic systemsJ Liégeois, V Seutin, J Scuvée-Moreau, et al.
Journal of Ethnopharmacology|September 22, 2005
Chemical and biological investigations of a toxic plant from Central Africa, Magnistipula butayei subsp. montanaC Karangwa, V Esters, M Frédérich, et al.
Journal De Pharmacie De Belgique|June 25, 1999
BM 144: an original thromboxane A2 receptor antagonist derived from torasemideJ M Dogné, P Neven, J Damas, et al.
European Journal of Pharmacology|August 22, 1996
Dibenzoazepine analogues: the electrophysiological properties of JL3, a potential atypical antidepressantJ F Liégeois, J Scuvée-Moreau, I Giesbers, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 20, 2008
Brain function in the minimally conscious state: a quantitative neurophysiological studyJ Leon-Carrion, J F Martin-Rodriguez, J Damas-Lopez, et al.
The Journal of Pharmacy and Pharmacology|August 24, 1999
Thromboxane A2 receptor antagonism in man and rat by a sulphonylcyanoguanidine (BM-144) and a sulphonylurea (BM-500)B Masereel, J Damas, J Fontaine, et al.
Presse Medicale (Paris, France : 1983)|February 6, 1988
[Hepatic protein synthesis of the kallikrein-kininogen-kinin system]A Adam, M Reynaert, P Damas, et al.
Journal of Medicinal Chemistry|April 26, 2000
3-Alkylamino-4H-pyrido[2,3-e]-1,2,4-thiadiazine 1,1-dioxides structurally related to diazoxide and pinacidil as potassium channel openers acting on vascular smooth muscle cells: design, synthesis, and pharmacological evaluationB Pirotte, R Ouedraogo, P de Tullio, et al.
Immunopharmacology|June 1, 1996
Effect of a serine proteinase inhibitor from Leucaena leucocephala on plasma kallikrein and plasminJ C Souza-Pinto, M L Oliva, C A Sampaio, et al.
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|January 1, 1985
[Salicylates and cortico-adrenal stimulation: myth or reality?]H Van Cauwenberge, J Lecomte, P Franchimont, et al.
Pageof 22

Showing results (201-210 of 219) with videos related to

Sort By:
Pageof 22
European Journal of Pharmacology|January 5, 2000
Effects of JL 3, a putative antidepressant, on rat noradrenergic and serotonergic systemsJ Liégeois, V Seutin, J Scuvée-Moreau, et al.
Journal of Ethnopharmacology|September 22, 2005
Chemical and biological investigations of a toxic plant from Central Africa, Magnistipula butayei subsp. montanaC Karangwa, V Esters, M Frédérich, et al.
Journal De Pharmacie De Belgique|June 25, 1999
BM 144: an original thromboxane A2 receptor antagonist derived from torasemideJ M Dogné, P Neven, J Damas, et al.
European Journal of Pharmacology|August 22, 1996
Dibenzoazepine analogues: the electrophysiological properties of JL3, a potential atypical antidepressantJ F Liégeois, J Scuvée-Moreau, I Giesbers, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 20, 2008
Brain function in the minimally conscious state: a quantitative neurophysiological studyJ Leon-Carrion, J F Martin-Rodriguez, J Damas-Lopez, et al.
The Journal of Pharmacy and Pharmacology|August 24, 1999
Thromboxane A2 receptor antagonism in man and rat by a sulphonylcyanoguanidine (BM-144) and a sulphonylurea (BM-500)B Masereel, J Damas, J Fontaine, et al.
Presse Medicale (Paris, France : 1983)|February 6, 1988
[Hepatic protein synthesis of the kallikrein-kininogen-kinin system]A Adam, M Reynaert, P Damas, et al.
Journal of Medicinal Chemistry|April 26, 2000
3-Alkylamino-4H-pyrido[2,3-e]-1,2,4-thiadiazine 1,1-dioxides structurally related to diazoxide and pinacidil as potassium channel openers acting on vascular smooth muscle cells: design, synthesis, and pharmacological evaluationB Pirotte, R Ouedraogo, P de Tullio, et al.
Immunopharmacology|June 1, 1996
Effect of a serine proteinase inhibitor from Leucaena leucocephala on plasma kallikrein and plasminJ C Souza-Pinto, M L Oliva, C A Sampaio, et al.
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|January 1, 1985
[Salicylates and cortico-adrenal stimulation: myth or reality?]H Van Cauwenberge, J Lecomte, P Franchimont, et al.
Pageof 22